1. Home
  2. ABCL vs SOC Comparison

ABCL vs SOC Comparison

Compare ABCL & SOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$9.44

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

SOC

Sable Offshore Corp.

HOLD

Current Price

$4.98

Market Cap

1.6B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ABCL
SOC
Founded
2012
2020
Country
Canada
United States
Employees
N/A
200
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.6B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ABCL
SOC
Price
$9.44
$4.98
Analyst Decision
Strong Buy
Buy
Analyst Count
5
4
Target Price
$8.40
$17.33
AVG Volume (30 Days)
6.1M
6.8M
Earning Date
05-11-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
10.91
N/A
EPS
N/A
N/A
Revenue
$75,128,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$21.85
$73.55
P/E Ratio
N/A
N/A
Revenue Growth
160.56
N/A
52 Week Low
$2.75
$2.88
52 Week High
$10.01
$29.81

Technical Indicators

Market Signals
Indicator
ABCL
SOC
Relative Strength Index (RSI) 77.04 46.36
Support Level $3.38 $3.95
Resistance Level N/A $5.33
Average True Range (ATR) 0.51 0.36
MACD 0.29 0.28
Stochastic Oscillator 87.97 71.84

Price Performance

Historical Comparison
ABCL
SOC

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

About SOC Sable Offshore Corp.

Sable Offshore Corp is a Houston-based independent upstream company focused on developing the Santa Ynez Unit in federal waters offshore California. The company operates as one reportable oil and gas segment and is engaged in the acquisition, development, exploration, and production of oil and natural gas.

Share on Social Networks: